Trevi Therapeutics Inc. (TRVI)
NASDAQ: TRVI
· Real-Time Price · USD
7.51
0.02 (0.27%)
At close: Aug 15, 2025, 3:59 PM
7.52
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT
Trevi Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.3M | -47.35M | -47.91M | -44.32M | -38.77M | -33.57M | -29.07M | -26.75M | -27.32M | -28.22M | -29.15M | -32.17M | -31.16M | -32.9M | -33.94M | -34.94M | -35.07M | -32.66M |
Depreciation & Amortization | 149K | 149K | 147K | 144K | 143K | 139K | 123K | 103K | 77K | 51K | 43K | 40K | 44K | 48K | 50K | 51K | 51K | 50K |
Stock-Based Compensation | 4.33M | 4.07M | 3.59M | 3.21M | 2.91M | 2.39M | 2.25M | 2.21M | 2.25M | 2.17M | 2.33M | 2.37M | 2.34M | 2.56M | 2.54M | 2.51M | 2.56M | 2.4M |
Other Working Capital | -376K | 3.47M | 5.22M | 6.12M | 3.48M | -2.25M | -985K | -2.51M | -2.23M | -760K | -1.24M | 1.2M | 1.1M | -14K | 678K | 40.37M | 41.46M | 40.87M |
Other Non-Cash Items | 4.84M | 4.89M | 4.91M | 5.14M | -231K | 231K | -88K | -682K | -875K | -907K | -162K | 455K | 680K | 994K | 974K | 976K | 893K | 372.97K |
Deferred Income Tax | n/a | n/a | n/a | 23K | -449K | -1.08M | -1.08M | -1.1M | -631K | n/a | n/a | -53K | -48K | -88K | -82K | -20K | -25K | 15K |
Change in Working Capital | -4.7M | -3.03M | 1.01M | 736K | 3.61M | -2.1M | -3.85M | -5.46M | -6.49M | -2.37M | -1.23M | 1.29M | 1.41M | 922K | 1.51M | -218K | 219K | -2.09M |
Operating Cash Flow | -42.68M | -41.27M | -38.26M | -35.06M | -32.79M | -33.98M | -31.71M | -31.68M | -32.98M | -29.28M | -28.18M | -28.07M | -26.74M | -28.46M | -28.95M | -31.64M | -31.37M | -31.91M |
Capital Expenditures | 13.47M | 13.44M | -35K | -50K | -68K | -80K | -137K | -231K | -256K | -216K | -159K | -43K | n/a | n/a | n/a | -5K | -20K | -32K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -671K | 530K | -1.43M | -1.43M | -757K | -1.96M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -102.9M | -95.75M | -98.46M | -54.22M | -41.17M | -31.21M | -9.93M | -74.17M | -80.98M | -135.2M | -126.22M | -61.02M | -54.22M | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 72.69M | 71.32M | 75.9M | 68.39M | 66.75M | 73.67M | 69.5M | 72.68M | 56.68M | 36.93M | 18.93M | 1.93M | -72K | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.45M | 1.07M | 1.07M | 1.07M | n/a | 19.68K | 690.68K | -510.32K | 1.45M | 1.5M | 829K | 2.03M | 72K | n/a | n/a | -32K | -32K | -32K |
Investing Cash Flow | -28.77M | -23.39M | -21.53M | 15.19M | 25.5M | 42.38M | 59.43M | -1.72M | -24.55M | -98.41M | -107.37M | -59.07M | -54.22M | n/a | n/a | -5K | -20K | -32K |
Debt Repayment | -74K | -105K | -126K | -127K | -126K | -7.79M | -9.5M | -11.22M | -12.94M | -7M | -5.83M | -4.08M | -2.33M | -583K | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 212K | 5.06M | 5.06M | 6.72M | 6.56M | 1.74M | 1.78M | 77K | 5.95M | 11.82M | 11.73M | 11.79M | 5.52M | -419K | -408K | -527K | 13.53M | 13.55M |
Financial Cash Flow | 175.54M | 70.22M | 61.48M | 9.96M | 6.5M | 1.42M | 1.45M | 2.15M | 55.94M | 111.93M | 111.31M | 124.4M | 69.23M | 16M | 20.77M | 7.67M | 23.63M | 20.87M |
Net Cash Flow | 104.09M | 5.56M | 1.7M | -9.91M | -789K | 2.16M | 19.81M | -40.61M | -10.95M | -17.46M | -24.24M | 37.26M | -11.73M | -12.46M | -8.17M | -23.98M | -7.75M | -11.07M |
Free Cash Flow | -42.69M | -41.3M | -38.29M | -35.12M | -32.86M | -34.06M | -31.85M | -31.91M | -33.23M | -29.5M | -28.33M | -28.12M | -26.74M | -28.46M | -28.95M | -31.65M | -31.39M | -31.94M |